Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test
HaluGen’s DNA genetic testing provides insights into the sensitivity and risks associated with psychedelic-assisted psychotherapy Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the